Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
733,992
-
Shares change
-
+57,170
-
Total reported value, excl. options
-
$110,709,985
-
Value change
-
+$8,525,948
-
Number of buys
-
23
-
Number of sells
-
52
-
Price
-
$150.79
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2019
As of 30 Jun 2019 ISHARES TR - U.S. PHARMA ETF (IHE) had 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 733,992 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BROWN ADVISORY INC, JANE STREET GROUP, LLC, ROYAL BANK OF CANADA, BIEGEL & WALLER LLC, MURPHY CAPITAL MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This table shows 104 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.